Current Biotechnology ›› 2025, Vol. 15 ›› Issue (4): 668-674.DOI: 10.19586/j.2095-2341.2024.0170
• Reviews • Previous Articles Next Articles
Received:2024-11-03
															
							
															
							
																	Accepted:2025-03-05
															
							
																	Online:2025-07-25
															
							
																	Published:2025-09-08
															
						Contact:
								Jinhui SHAO   
													通讯作者:
					邵金辉
							作者简介:董子涵 E-mail:2714928569@qq.com;
				
							基金资助:CLC Number:
Zihan DONG, Jinhui SHAO. The Effect of SP140 Protein on the Expression Regulation of Several Tumor or Infection Related Genes and Some Immune Diseases[J]. Current Biotechnology, 2025, 15(4): 668-674.
董子涵, 邵金辉. SP140蛋白对几种肿瘤或感染相关基因表达调控和一些免疫性疾病的影响[J]. 生物技术进展, 2025, 15(4): 668-674.
| 疾病类型 | 与SP140有关的疾病 | 
|---|---|
| 自身免疫性疾病 | 原发性胆汁性肝硬化、克罗恩病、多发性硬化症、炎症性肠病、川崎病、慢性淋巴细胞白血病、艾滋病 | 
| 恶性肿瘤 | 淋巴瘤C3、喉鳞状细胞癌、宫颈鳞状细胞癌 | 
| 感染性疾病 | 嗜肺军团菌感染、结核分枝杆菌感染 | 
| 神经系统及眼部疾病 | 视网膜神经退行性疾病 | 
| 睡眠相关疾病 | 过度日间嗜睡、睡眠呼吸障碍、阻塞性睡眠呼吸暂停 | 
Table 1 Diseases associated with SP140
| 疾病类型 | 与SP140有关的疾病 | 
|---|---|
| 自身免疫性疾病 | 原发性胆汁性肝硬化、克罗恩病、多发性硬化症、炎症性肠病、川崎病、慢性淋巴细胞白血病、艾滋病 | 
| 恶性肿瘤 | 淋巴瘤C3、喉鳞状细胞癌、宫颈鳞状细胞癌 | 
| 感染性疾病 | 嗜肺军团菌感染、结核分枝杆菌感染 | 
| 神经系统及眼部疾病 | 视网膜神经退行性疾病 | 
| 睡眠相关疾病 | 过度日间嗜睡、睡眠呼吸障碍、阻塞性睡眠呼吸暂停 | 
| [1] | ZUCCHELLI C, TAMBURRI S, FILOSA G, et al.. Sp140 is a multi-SUMO-1 target and its PHD finger promotes SUM Oylation of the adjacent Bromo domain[J]. Biochim. Biophys. Acta Gen. Subj., 2019, 1863(2): 456-465. | 
| [2] | FRASCHILLA I, JEFFREY K L. The speckled protein (SP) family: immunity's chromatin readers[J]. Trends Immunol., 2020, 41(7): 572-585. | 
| [3] | SAARE M, HÄMARIK U, VENTA R, et al.. SP140L, an evolutionarily recent member of the SP100 family, is an autoantigen in primary biliary cirrhosis[J/OL]. J. Immunol. Res., 2015, 2015: 526518[2025-03-10]. . | 
| [4] | AMATULLAH H, FRASCHILLA I, DIGUMARTHI S, et al.. Epigenetic reader SP140 loss of function drives Crohn's disease due to uncontrolled macrophage topoisomerases[J]. Cell, 2022, 185(17): 3232-3247. | 
| [5] | BLOCH D B, DE LA MONTE S M, GUIGAOURI P, et al.. Identification and characterization of a leukocyte-specific component of the nuclear body[J]. J. Biol. Chem., 1996, 271(46): 29198-29204. | 
| [6] | ZUCCHELLI C, TAMBURRI S, QUILICI G, et al.. Structure of human Sp140 PHD finger: an atypical fold interacting with Pin1[J]. FEBS J., 2014, 281(1): 216-231. | 
| [7] | BLOCH D B, NAKAJIMA A, GULICK T, et al.. Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator[J]. Mol. Cell. Biol., 2000, 20(16): 6138-6146. | 
| [8] | BLOCH D B, DCHICHE J, ORTH D, et al.. Structural and functional heterogeneity of nuclear bodies[J]. Mol. Cell. Biol., 1999, 19(6): 4423-4430. | 
| [9] | BOCOVA L, HUBENS W, ENGEL C, et al.. Quantification of hematopoietic stem and progenitor cells by targeted DNA methylation analysis[J/OL]. Clin. Epigenet., 2023, 15(1): 105[2025-03-10]. . | 
| [10] | LUO Y, SUN F, PENG X, et al.. Integrated bioinformatics analysis to identify abnormal methylated differentially expressed genes for predicting prognosis of human colon cancer[J]. Int. J. Gen. Med., 2021, 14: 4745-4756. | 
| [11] | JI D X, WITT K C, KOTOV D I, et al..Role of the transcriptional regulator SP140 in resistance to bacterial infections via repression of type I interferons[J/OL].Elife, 2021, 10:e67290[2025-03-10]. . | 
| [12] | NAKAMURA H, HIKICHI H, SETO S, et al.. Transcriptional regulators SP110 and SP140 modulate inflammatory response genes in Mycobacterium tuberculosis-infected human macrophages[J/OL]. Microbiol. Spectr., 2024, 12(10): e0010124[2025-03-10]. . | 
| [13] | SUMIDA T S, DULBERG S, SCHUPP J C, et al.. Type 1 interferon transcriptional network regulates expression of coinhibitory receptors in human T cells[J]. Nat. Immunol., 2022, 23(4): 632-642. | 
| [14] | ZHANG T, LIU H, JIAO L, et al.. Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL[J/OL]. J. Immunother. Cancer, 2022, 10(4): e004114[2025-03-10]. . | 
| [15] | GHIBOUB M, BELL M, SINKEVICIUTE D, et al.. The epigenetic reader protein SP140 regulates dendritic cell activation, maturation and tolerogenic potential[J]. Curr. Issues Mol. Biol., 2023, 45(5): 4228-4245. | 
| [16] | GHIBOUB M, KOSTER J, CRAGGS P D, et al.. Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140[J/OL]. BMC Biol., 2022, 20(1): 182[2025-03-10]. . | 
| [17] | TANAGALA K K K, MORIN-BAXTER J, CARVAJAL R, et al.. SP140 inhibits STAT1 signaling, induces IFN-γ in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response[J/OL]. J. Immunother. Cancer, 2022, 10(12): e005088[2025-03-10]. . | 
| [18] | LI Z, XUE Y, HUANG X, et al.. Stratifying osteosarcoma patients using an epigenetic modification-related prognostic signature: implications for immunotherapy and chemotherapy selection[J]. Transl. Cancer Res., 2024, 13(7): 3556-3574. | 
| [19] | MATSUSHITA K, LI X, NAKAMURA Y, et al.. The role of Sp140 revealed in IgE and mast cell responses in Collaborative Cross mice[J/OL]. JCI Insight, 2021, 6(12): e146572[2025-03-10]. . | 
| [20] | KARAKY M, FEDETZ M, POTENCIANO V, et al.. SP140 regulates the expression of immune-related genes associated with multiple sclerosis and other autoimmune diseases by NF-κB inhibition[J]. Hum. Mol. Genet., 2018, 27(23): 4012-4023. | 
| [21] | WEINER A B, YU C Y, KINI M, et al.. High intratumoral plasma cells content in primary prostate cancer defines a subset of tumors with potential susceptibility to immune-based treatments[J]. Prostate Cancer Prostatic Dis., 2023, 26(1): 105-112. | 
| [22] | SHEN Y, NUSSBAUM Y I, MANJUNATH Y, et al.. TBX21 methylation as a potential regulator of immune suppression in CMS1 subtype colorectal cancer[J/OL]. Cancers, 2022, 14(19): 4594[2025-03-10]. . | 
| [23] | GRANITO A, YANG W H, MURATORI L, et al.. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis[J]. Am. J. Gastroenterol., 2010, 105(1): 125-131. | 
| [24] | MATESANZ F, POTENCIANO V, FEDETZ M, et al.. A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis[J]. Hum. Mol. Genet., 2015, 24(19): 5619-5627. | 
| [25] | PERES L C, COLIN-LEITZINGER C M, TENG M, et al.. Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma[J]. Blood Adv., 2022, 6(12): 3767-3778. | 
| [26] | MEHTA S, CRONKITE D A, BASAVAPPA M, et al.. Maintenance of macrophage transcriptional programs and intestinal homeostasis by epigenetic reader SP140[J/OL]. Sci. Immunol., 2017, 2(9): eaag3160[2025-03-10]. . | 
| [27] | PUTSCHER E, HECKER M, FITZNER B, et al.. Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing[J/OL]. Front. Immunol., 2022, 13: 931831[2025-03-10]. . | 
| [28] | SADDALA M S, YANG X, TANG S, et al.. Transcriptome-wide analysis reveals core sets of transcriptional regulators of sensome and inflammation genes in retinal microglia[J]. Genomics, 2021, 113(5): 3058-3071. | 
| [29] | LI X, LI G, LI L, et al.. SP140 inhibitor suppressing TRIM22 expression regulates glioma progress through PI3K/AKT signaling pathway[J/OL]. Brain Behav., 2024, 14(3): e3465[2025-03-10]. . | 
| [30] | 刘梦昱, 谢飞, 张鑫, 等. 胶质母细胞瘤免疫治疗研究进展[J]. 生物技术进展, 2019, 9(3): 223-230. | 
| LIU M Y, XIE F, ZHANG X, et al.. Review of immunotherapy for glioblastoma[J]. Curr. Biotechnol., 2019, 9(3): 223-230. | |
| [31] | ZHOU H, WU L, YU L, et al.. Identify a DNA damage repair gene signature for predicting prognosis and immunotherapy response in cervical squamous cell carcinoma[J/OL]. J. Oncol., 2022, 2022: 8736575[2025-03-10]. . | 
| [32] | YU B, GENG C, WU Z, et al.. A CIC-related-epigenetic factors-based model associated with prediction, the tumor microenvironment and drug sensitivity in osteosarcoma[J/OL]. Sci. Rep., 2024, 14(1): 1308[2025-03-10]. . | 
| [33] | KAROLOVÁ J, KAZANTSEV D, SVATOŇ M, et al.. Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy[J]. Am. J. Hematol., 2023, 98(10): 1627-1636. | 
| [34] | FRASCHILLA I, AMATULLAH H, URAHMAN R, et al.. Immune chromatin reader SP140 regulates microbiota and risk for inflammatory bowel disease[J]. Cell Host Microbe, 2022, 30(10): 1370-1381. | 
| [35] | CHEN Y C, CHEN T W, SU M C, et al.. Whole genome DNA methylation analysis of obstructive sleep apnea: IL1R2, NPR2, AR, SP140 methylation and clinical phenotype[J]. Sleep, 2016, 39(4): 743-755. | 
| [36] | REINDEL R, BISCHOF J, KIM K Y A, et al.. CD84 is markedly up-regulated in Kawasaki disease arteriopathy[J]. Clin. Exp. Immunol., 2014, 177(1): 203-211. | 
| [37] | 周建荣, 傅仲学, 魏莲枝, 等. 蛋白质组学方法鉴定喉鳞状细胞癌中的肿瘤相关蛋白[J]. 中华耳鼻咽喉头颈外科杂志, 2007, 42(12): 934-938. | 
| ZHOU J R, FU Z X, WEI L Z, et al.. Identification of tumor-associated proteins in laryngeal squamons cell carcinoma by proteomics[J]. Chin. J. Otorhinolaryngol. Head Neck Surg., 2007, 42(12): 934-938. | |
| [38] | MADANI N, MILLETTE R, PLATT E J, et al.. Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1[J]. J. Virol., 2002, 76(21): 11133-11138. | 
| [39] | DZIULKO A K, ALLEN H, CHUONG E B. An endogenous retrovirus regulates tumor-specific expression of the immune transcriptional regulator SP140Free[J]. Hum. Mol. Genet., 2024, 33(16): 1454-1464. | 
| [40] | YI S, YAN Y, JIN M, et al.. Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma[J/OL]. J. Clin. Invest., 2022, 132(3): e153283[2025-03-10]. . | 
| [41] | JIANG P, DESAI A, YE H. Progress in molecular feature of smoldering mantle cell lymphoma[J/OL]. Exp. Hematol. Oncol., 2021, 10(1): 41[2025-03-10]. . | 
| [1] | Lina ZHU, Zhiling SONG. Autophagy and Apoptosis: Interactions and Their Role in Disease [J]. Current Biotechnology, 2025, 15(4): 622-626. | 
| [2] | Lingfei WAN, Wenting PAN, Yuting YONG, Yuanshuai LI, yue ZHAO, Xinlong YAN. Research Progress in Spatial Transcriptomics Technology for Liver Disease Research [J]. Current Biotechnology, 2025, 15(4): 645-654. | 
| [3] | Yanhua LIU, Rui GUO, Yanyi LI, Jinli CHEN. Progress on the Development of Vaccines Related to Chronic Respiratory Diseases [J]. Current Biotechnology, 2025, 15(3): 396-403. | 
| [4] | Yanhua LIU, Rui GUO, Yanyi LI, Jinli CHEN. GLP-1 Receptor Agonists: Emerging Therapeutic Strategy for Parkinson's Disease [J]. Current Biotechnology, 2025, 15(3): 404-410. | 
| [5] | Ruoliu ZHANG, Mingwei BAO. Research Progress on the Role of Toll-like Receptor 7 in Cardiovascular Diseases [J]. Current Biotechnology, 2025, 15(2): 247-253. | 
| [6] | Hao LIU, Xiang LI. Research Progress on Pathogenic Mechanisms and Treatment Strategy of Coronary Artery Disease [J]. Current Biotechnology, 2025, 15(2): 254-262. | 
| [7] | Zhuoying LIU, Xiaojin ZHOU, Yanli HUANG, Sen PANG. Joint Transcriptome Analysis of Maize Under Salt Stress and MeJA Treatment [J]. Current Biotechnology, 2025, 15(2): 263-275. | 
| [8] | Wenxuan PU, Xi DAI, Jiani YUE, Xiuxia FU, Na SONG, Wei LI, Yu PENG. Research Progress of Iron Signaling and its Role in Plant-pathogen Interaction [J]. Current Biotechnology, 2025, 15(1): 1-10. | 
| [9] | Caihua LI, Yankun ZHAO, Zhankun LI, Zilong SHAN, Qiao CAO, Liang MA, Fei WANG, Zhenxian GAO. Research Progress on Rht Genes in Wheat [J]. Current Biotechnology, 2024, 14(6): 980-992. | 
| [10] | Lingling XIAO, Mingwei BAO. Roles of Interleukin-22 in Cardiovascular Disease [J]. Current Biotechnology, 2024, 14(5): 820-824. | 
| [11] | Yiwei ZHAO, Tianlu GAO, Jiahui ZHANG, Yuqi WANG, Pan CHANG, Hong WANG. Research Progress on the Imbalance of Mitochondrial Quality Control Leading to Renal Interstitial Fibrosis in Diabetic Kidney Disease [J]. Current Biotechnology, 2024, 14(5): 825-831. | 
| [12] | Min LIU, Huai CHENG, Huanchang CAI, Hewei ZHANG, Jingqiang REN. Application of Degenerate PCR Technique in Disease Detection [J]. Current Biotechnology, 2024, 14(4): 545-554. | 
| [13] | Hongbo LI, Zhuyue CHEN, Xinxing LYU. Recent Progress on Spermidine Alleviating Cell Senescence and Aging-related Diseases [J]. Current Biotechnology, 2024, 14(3): 388-398. | 
| [14] | Zhaoqing XI, Mingwei BAO. Research Progress on Glycolipid Metabolism Reprogramming of Macrophage in Non-alcoholic Fatty Liver Disease [J]. Current Biotechnology, 2024, 14(3): 399-405. | 
| [15] | Man LIU, Yongxi HUANG, Pupu YAN, Jiali LIU, Liwei GUO. Identification of Shared Genetic Characteristics and Biological Mechanisms of Newcastle Disease and Streptococcal Disease in Chickens Based on the GEO Database [J]. Current Biotechnology, 2024, 14(3): 451-458. | 
| Viewed | ||||||
| Full text |  | |||||
| Abstract |  | |||||
